Mealey's (June 10, 2021, 9:15 AM EDT) -- GREENBELT, Md. — Vaccine manufacturer Emergent BioSolutions Inc. and certain of its current and former senior executives violated federal securities laws by misrepresenting the company’s ability to manufacture millions of doses of COVID-19 vaccines and its emphasis on quality controls before the company’s forced destruction of million of doses of vaccines due to possible contamination, a shareholder alleges in a securities class action complaint filed June 2 in Maryland federal court....